SomnoMed posts 30% revenue growth for FY2018
Filed with ASX · · 2 pages · English
Earlier from Somnomed
- Trading Update
- Retail Entitlement Offer Information Booklet
- Successful completion of Institutional Entitlement Offer
- Accelerated non-renounceable entitlement offer
- ASX Market Release - Trading Halt
Later from Somnomed
- Full year results and the consolidation of RSS operations
- Strong first quarter in Core business diluted by RSS results
- Response to Appendix 4C Query
- Change in Leadership of SomnoMed
- 2018 AGM addresses - Chairman and CEO
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed